Sponsor

Bold Therapeutics Inc.

422 Richards Street Suite 170, V6B 2Z4

About the sponsor

Bold Therapeutics Inc. focuses on advanced solid gastrointestinal tumours, with research activity spanning colorectal cancer, gastric cancer, and broader gastrointestinal malignancies.

Advanced solid gastrointestinal tumours
Colorectal cancer
Gastric cancer

The sponsor’s clinical research in this area reflects a strong therapeutic interest in difficult-to-treat digestive system cancers.

About Specializations

Bold Therapeutics Inc. runs clinical trials in conditions such as Gastric cancer, Colorectal cancer, Pancreatic carcinoma, Cholangiocarcinoma, among others.

Recruiting now